Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|9|6|482-501

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.9, Iss.6, 2008-12, pp. : 482-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fc-fusion Proteins in Therapy: An Updated View

By  

Current Medicinal Chemistry, Vol. 24, Iss. 12, 2017-06 ,pp. : 1228-1237

Bentham Science Publishers

Access to resources Recommend Favorite

Fc Engineering to Improve the Function of Therapeutic Antibodies

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1298-1314

Bentham Science Publishers

Access to resources Recommend Favorite

Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering

By Wang Yuan   Tian Zehua   Thirumalai Diraviyam   Zhang Xiaoying  

Journal of Drug Targeting, Vol. 22, Iss. 4, 2014-05 ,pp. : 269-278

Informa Healthcare

Access to resources Recommend Favorite

GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins

By Beck Alain   Cochet Olivier   Wurch Thierry  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 95-111

Informa Healthcare

Access to resources Recommend Favorite

Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1333-1347

Bentham Science Publishers

Access to resources Recommend Favorite